ProQR Therapeutics (PRQR) Current Assets (2021 - 2024)
Historic Current Assets for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $164.4 million.
- ProQR Therapeutics' Current Assets rose 2629.13% to $164.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $164.4 million, marking a year-over-year increase of 2629.13%. This contributed to the annual value of $166.5 million for FY2024, which is 2723.23% up from last year.
- Per ProQR Therapeutics' latest filing, its Current Assets stood at $164.4 million for Q4 2024, which was up 2629.13% from $130.2 million recorded in Q4 2023.
- Over the past 5 years, ProQR Therapeutics' Current Assets peaked at $219.1 million during Q4 2021, and registered a low of $87893.6 during Q1 2021.
- In the last 4 years, ProQR Therapeutics' Current Assets had a median value of $157.6 million in 2022 and averaged $150.3 million.
- Within the past 5 years, the most significant YoY rise in ProQR Therapeutics' Current Assets was 22013299.48% (2022), while the steepest drop was 4972.96% (2022).
- ProQR Therapeutics' Current Assets (Quarter) stood at $219.1 million in 2021, then fell by 28.06% to $157.6 million in 2022, then fell by 17.4% to $130.2 million in 2023, then increased by 26.29% to $164.4 million in 2024.
- Its Current Assets was $164.4 million in Q4 2024, compared to $130.2 million in Q4 2023 and $135.7 million in Q3 2023.